Five Below (FIVE) Reports Strong Results and Guidance to Send Shares 6% Higher and Prompt Analysts to Hike PTs

Five Below (FIVE) PT Raised to $300 at Jefferies

Jefferies analyst Randal Konik raised the price target on Five Below (NASDAQ: FIVE) to $300.00 (from $260.00) while maintaining a Buy rating following earnings.

Five Below (FIVE) PT Raised to $254 at Deutsche Bank

Deutsche Bank analyst Paul Trussell raised the price target on Five Below (NASDAQ: FIVE) to $254.00 (from $252.00) while maintaining a Buy rating.... More

Five Below (FIVE) PT Raised to $234 at RBC Capital

RBC Capital analyst Scot Ciccarelli raised the price target on Five Below (NASDAQ: FIVE) to $234.00 (from $225.00) while maintaining a Outperform rating.... More

Five Below (FIVE) PT Raised to $240 at Telsey

Telsey analyst Joseph Feldman raised the price target on Five Below (NASDAQ: FIVE) to $240.00 (from $230.00) while maintaining a Outperform rating.... More

After-Hours Stock Movers 06/03: (SENS) (ASAN) (FIVE) Higher; (PSTH) (PD) (SUMO) Lower (more...)

Today's After-Hours Movers

Senseonics Holdings, Inc. (NYSE: SENS) 35% HIGHER; announced the results of the PROMISE Study evaluating the accuracy and safety of the next generation Eversense CGM System for up to 180 days with reduced calibrations. The data was presented by Satish Garg, MD, Professor of Medicine at the Barbara Davis Center of the University of Colorado, Denver, and the study group Principal Investigator (PI), as an oral presentation at the 14th Annual ATTD Meeting. Results were presented for both the primary sensor and for a secondary... More

Five Below (FIVE) Tops Q1 EPS by 23c, Revenue and Q2 Guidance Beat Consensus

Five Below (NASDAQ: FIVE) reported Q1 EPS of $0.88, $0.23 better than the analyst estimate of $0.65. Revenue for the quarter came in at $597.8 million versus the consensus estimate of $551.14 million.

GUIDANCE:

Five Below sees Q2 2021 EPS of $1.01-$1.13, versus the consensus... More